Data show verekitug prevents TSLP binding to the TSLP receptor by occupying ligand binding sites –– Additionally, findings show that verekitug ...

PHILADELPHIA--(BUSINESS WIRE)--Latus Bio, Inc. (Latus), a biotechnology company pioneering advances in AAV gene therapy, is pleased to announce data presentations in support of its preclinical drug ...

Yatiri Bio Inc. today announced it has received a grant from the Gates Foundation to launch a one-year project, Proteomics Interoperability, aimed at improving how large-scale proteomics data can be ...

MindWalk Holdings Corp. reported record sales, improved margins, and a strengthened balance sheet post-divestiture. Learn ...

U.S. biotech firm Nabla Bio said on Tuesday it has signed a second major research partnership with Japanese drugmaker Takeda ...

bbT369, a dual-targeted (CD79a/CD20) and CBLB gene edited autologous CAR T for non-Hodgkin lymphoma, showed edit-driven enhanced T cell activity in multiple preclinical models RESET, a novel TCR ...

For the first time, scientists can now leverage the reproducibility of ioCells to study how the four major CNS cell types interact and contribute to neurological diseases. This enables more precise ...

CellCodex has been established by an experienced team with a mission to provide better biological data to train advanced ...

An update from Collplant Holdings ( ($CLGN) ) is now available. On October 16, 2025, CollPlant Biotechnologies announced the development of a ...

Bio Protocol raises $6.9M in seed funding led by Arthur Hayes’ Maelstrom Fund to expand its decentralised science initiatives.